This Microsoft Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

featured-image

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Keybanc analyst Jackson Ader downgraded the rating for Microsoft Corporation (NASDAQ:MSFT) from Overweight to Sector Weight. Microsoft shares closed at $371.61 on Wednesday. See how other analysts view this stock.Laidlaw & Co. analyst Yale Jen downgraded iCAD, Inc. (NASDAQ:ICAD) from Buy ...Full story available on Benzinga.com

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page . Keybanc analyst Jackson Ader downgraded the rating for Microsoft Corporation MSFT from Overweight to Sector Weight.

Microsoft shares closed at $371.61 on Wednesday. See how other analysts view this stock .



Laidlaw & Co. analyst Yale Jen downgraded iCAD, Inc. ICAD from Buy to Hold.

iCAD shares closed at $3.07 on Wednesday. See how other analysts view this stock .

Keybanc analyst Steve Barger downgraded Amkor Technology, Inc . AMKR from Overweight to Sector Weight. Amkor Tech shares closed at $16.

15 on Wednesday. See how other analysts view this stock . BMO Capital analyst Evan David Seigerman downgraded Novo Nordisk A/S NVO from Outperform to Market Perform and lowered the price target from $105 to $64.

Novo Nordisk shares closed at $62.88 on Wednesday. See how other analysts view this stock .

Keybanc analyst Steve Barger downgraded the rating for Teradyne, Inc. TER from Overweight to Sector Weight. Teradyne shares closed at $71.

16 on Wednesday. See how other analysts view this stock. Considering buying MSFT stock? Here’s what analysts think: Read This Next: Netflix, UnitedHealth Group And 3 Stocks To Watch Heading Into Thursday Photo via Shutterstock Stock Score Locked: Want to See it? Benzinga Rankings give you vital metrics on any stock – anytime.

© 2025 Benzinga.com. Benzinga does not provide investment advice.

All rights reserved..